NATCO PHARMA LIMITED: CO. LAUNCHES CARBOPLATIN INJECTION, A GENERIC VERSION OF PARAPLATIN® IN THE U.S. MARKET; PRODUCT ADDRESSES CRITICAL SHORTAGE; ESTIMATED SALES OF USD 27.8 MILLIONt.me/bazaarupdate/109433October 19, 2026 659